Current role
Biotechnology · Healthcare
Board Member
2025-09-08–present
Roger Dansey, M.D.
Board Member
Bicycle Therapeutics PLC (BCYC)Equibles does not estimate personal net worth.
Get an email with a short summary when Bicycle Therapeutics PLC publishes a filing, an earnings call transcript or a press release.
Get BCYC alertsAbout Roger Dansey, M.D.
Roger Dansey, M.D. is recorded as Board Member at Bicycle Therapeutics PLC (BCYC) since September 8, 2025. Bicycle Therapeutics PLC reported in an 8-K filed September 8, 2025 that Roger Dansey, M.D. was appointed Class III director, effective September 8, 2025. Bicycle Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Bicycle Therapeutics PLC includes Kevin Lee (CEO and Board Member), Felix J. Baker, Ph.D. (Chairman and Board Member), Pierre Legault (Chairman) and 7 others.
“Effective as of September 8, 2025, the Board of Directors (the "Board") of Bicycle Therapeutics plc (the "Company") increased the size of the Board from eight to ten directors and, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed (i) Roger Dansey, M.D., to the Board as a Class III director, for a term expiring at the Company's 2028 annual general meeting”
Affiliation history
-
Current
2025-09-08–present
Company network
Leadership on record at Bicycle Therapeutics PLC
- Kevin Lee CEO, Board Member
- Felix J. Baker, Ph.D. Chairman, Board Member
- Pierre Legault Chairman
- Alethia Young CFO
- Travis Thompson CFO, Chief Accounting Officer
- Alistair Milnes COO
- Jennifer Perry COO
- Jennifer Perry, Pharm.D. COO
- Michael Skynner COO, CTO
- Alessandro Riva, M.D. Board Member